Abstract：Objective: To explore the significance of pharmaceutical cure care provided by clinical pharmacists for patients with ketamine-associated urinary system injury. Methods: According to this case, the process of diagnosis and treatment was analyzed emphatically due to provide pharmaceutical care accurately. Results: Clinical pharmacists put forward rational treatment recommendations based on the diagnosis and cure on the disease so as to supply individualized therapeutic care for patients with ketamine-associated urinary system injury. Conclusion: Clinical pharmacists set up an individualized therapeutic regimen in cooperation with physicians to enhance the safety and effectiveness as well as coming up with the concept of psychosomatic pharmacy.
叶永琴 ,李秦川. 临床药师对1例氯胺酮相关性尿路系统损害病例的药学监护[J]. 临床药物治疗杂志, 2016, 14(5): 71-74.
YE Yong-qin , LI Qin-chuan. Pharmaceutical care for a patient with ketamine-associated urinary system injury by clinical pharmacists.. CLINICAL MEDICATION JOURNAL, 2016, 14(5): 71-74.
[1] Chen C, Lee M, Chen Y, et al. Ketamine-snorting associated cystitis[J]. J Formosan Med Association, 2011, 110(12): 787-791.
[2] Yee C, Lai P, Lee W, et al. Clinical outcome of a prospective case series of patients with ketamine cystitis who underwent standardized treatment protocol[J]. Urology, 2015, 86(2): 236-243.
[3] Lim C, Su C, Liu C, et al. Clinical findings and Treatment of ketamine cystitis: 8 years experience of chimei medical center[J]. Urological Sci, 2015, 26(Suppl 1): S54.
[4] García-Larrosa A, Castillo C, Ventura M, et al. Cystitis and ketamine-associated bladder dysfunction[J]. Actas urológicas espa?olas (English Edition), 2012, 36(1): 60-64.
[5] Yongqing L, Song W, Liangchao N, et al. Ketamine-associated urinary tract dysfunction: an underrecognized clinical entity.[J]. Urologia Internationalis, 2012, 89(1): 93-96.
[6] Yang H Z, Xiong L J, Feng W W, et al. Clinical analysis of ketamine-associated urinary tract dysfunction:a report of 35 cases[J]. J Shanxi Med University, 2011, (4):346-348.
[7] Hung C, Lin C. Surgical treatment of ketamine-associated ulcerative cystitis: 8-year experience at Cathay General Hospital and review of series[J]. Urological Sci. 2015, 26(Suppl): S59.
[8] Chu P S K, Kwok S C, Lam K M, et al. 'Street ketamine'-associated bladder dysfunction: a report of ten cases.[J]. Hong Kong Academy Med, 2007, 13(4): 311-313.
[9] Ma W, Chu P S. Burden of ketamine cystitis in Chinese society[J]. Urological Sci, 2015, 26(3): 167-173.
[10] Kuo W, Wang H, Yu T, et al. Bladder augmentation in ketamine associated cystitis[J]. Urological Sci, 2015, 26(Supplement): S11-S12.
[11] Meng E, Tsao C, Tang S, et al. Intravesical hyaluronic acid treatment for ketamine-associated cystitis: Preliminary results[J]. Urological Sci, 2015, 26(3): 176-179.
[12] Chen H. A novel urological issue: Ketamine cystitis[J]. Urological Sci, 2015, 26(3): 180-181.
[13] Tsai Y C, Kuo H. Ketamine cystitis: Its urological impact and management[J]. Urological Sci, 2015, 26(3): 153-157.
[14] Lee H, Hsu Y, Hsu C, et al. Upper urinary tract damage caused by ketamine snorting—A report of nine cases[J]. Urological Sci, 2015, 26(3): 182-185.
[15] Marri S R. Adjuvant agents in regional anaesthesia[J]. Anaesthesia & Intensive Care Med, 2015, 16(11): 570-573.
[16] Rasmussen K G. Has psychiatry tamed the “ketamine tiger?” Considerations on its use for depression and anxiety[J]. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 2016, 64: 218-224.
[17] Laforgue E, Sauvaget A, Bulteau S, et al. Intérêts de la kétamine : de l’effet antidépresseur à l’effet anti-suicide ?[J]. Annales Médico-psychologiques, revue psychiatrique. 2016, 174(1):60-63.
[18] Smart C, Kabir M, Pati J. Treatment of ketamine-associated cystitis with chondroitin sulphate.[J]. Br J Nurs, 2013, 22(18): S4, S6, S8-S9.
[19] Meng E. Ketamine cystitis—A long-lasting burning issue in Taiwan[J]. Urological Sci, 2015, 26(3): 158-159.
2016, Vol. 14 
